MedPath

NRA-TADALAFIL TABLETS

NRA-TADALAFIL TABLETS

Approved
DIN Number

02452499

Drug Class

Human

Market Date

Jul 13, 2016

Company
HC

nora pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02452499
AIG Number0149485001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G04BE08 TADALAFIL
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:12.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

TADALAFILActive
Strength: 10 MG
Monograph: TADALAFIL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.